Boehringer-Ingelheim PRESENTATION #PLA2019

Past, present and future of informatics in the laboratory


The keynote will be a journey through the last 20 years of laboratory informatics, highlighting the driving forces that mostly contributed to the creation of the current landscape.

We will fast forward to the present and touch base on the topics that are more prominently driving the conversation in the pharma industry, particularly compliance and data integrity. Examples of what Boehringer-Ingelheim is doing about it will be provided, namely its standardized chromatography management system and interfaces, data archival strategy and its contribution to the Allotrope Foundation.

Finally, we will look at the future of laboratory informatics, how innovation and technology are providing an almost irresistible push for change and what the pharma industry should do in order to be ready for it.




SNasi Paperless Lab Academy

Name: Sergio Nasi

Title: Head of IT RDM LIMS Services

Company: Boehringer-Ingelheim

Sergio has been in the laboratory informatics business since the year 2000 and worked predominantly in the Laboratory Information Management Systems domain ever since, in several companies and under various roles: developer, consultant, business analyst, project manager, and team lead.

Having a passion for cats and technology, Sergio thinks that an innovation-driven pharmaceutical corporation and a top player in the Animal Health business just seems the right place to be.

Boehringer Ingelheim paperless lab academy

Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies.

Family-owned since it was established in 1885, its workforce of 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health, and biopharmaceuticals.

In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 percent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company, therefore, aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research.

Corporate website: